Nasopharyngeal carcinoma secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
EBV-associated antibodies may be helpful for secondary prevention of [[nasopharyngeal carcinoma]]. | EBV-associated antibodies may be helpful for secondary prevention of [[nasopharyngeal carcinoma]]. | ||
===Follow up after treatment=== | ===Follow up after treatment=== | ||
After treatment, patients with nasopharyngeal carcinoma should follow up for prevention | After treatment, patients with nasopharyngeal carcinoma should follow up for secondary prevention. Follow up includes: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | ||
Line 24: | Line 24: | ||
*Every 1-3 months for 1st year after treatment | *Every 1-3 months for 1st year after treatment | ||
*Every 2-6 months for 2nd year after treatment | *Every 2-6 months for 2nd year after treatment | ||
*Every 4-8 months | *Every 4-8 months between 3 and 5 years after treatment | ||
* | *Annually after 5 years | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
:Nasendoscopy | :Nasendoscopy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Immediately after radiation therapy | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
Line 49: | Line 49: | ||
:Dental screening | :Dental screening | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Only | *Only recommended if oral cavity is exposed to radiations | ||
|- | |- | ||
|} | |} |
Revision as of 15:37, 29 September 2015
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma secondary prevention On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma secondary prevention |
Risk calculators and risk factors for Nasopharyngeal carcinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
EBV-associated antibodies may be helpful for secondary prevention of nasopharyngeal carcinoma.
Secondary Prevention
EBV-associated antibodies may be helpful for secondary prevention of nasopharyngeal carcinoma.
Follow up after treatment
After treatment, patients with nasopharyngeal carcinoma should follow up for secondary prevention. Follow up includes:
Follow up | Description |
---|---|
|
|
|
|
|
Scans are performed at routine intervals as follows:
|
|
|
|
|